Skip to main content

Szukaj

Reset all filters
103 Result(s)
Sortuj według

Submit Your Opportunity

Submit Your Opportunity

Information on how to submit a partnering opportunity direct to Boehringer Ingelheim’s Business Development & Licensing team
Eprinex®

Eprinex®

Depending on formulation, the product is for the treatment of nematodes, lice, mites, ticks, flies and lungworms in cattle and sheep.
Broadline®

Broadline®

Protects cats against the broadest spectrum of internal and external parasites including adult fleas, flea eggs, flea larvae, ticks, heartworms, hookworms, roundworms, and tapeworms.
A Clear Vision

A Clear Vision

Take a tour of our journey into Retinal Health through this interactive infographic or descriptive audio recording, and learn how we aim to preserve or restore vision in people with retinal diseases.
Championing novel science

Championing novel science

Dr. Vikas Mohan Sharma announces FDA fast-track designation for BI 1358894 as potential treatment for Borderline Personality Disorder.
SIRPα Cancer Immunology Research

SIRPα Cancer Immunology Research

Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
BI Access to Healthcare Strategy_Availability

BI Access to Healthcare Strategy_Availability

Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Antibody therapeutics business partnering PetMedix

Antibody therapeutics business partnering PetMedix

Combining PetMedix’ expertise in veterinary biotherapeutic technology with Boehringer Ingelheim’s long experience and innovation in human antibody discovery and development provides a unique opportunity for the partners.
Behind the Lab

Behind the Lab

Delve behind the lab to see how our Retinal Health scientists are spearheading research into novel therapeutics to treat retinopathies.
Be green Japan

Be green Japan

Boehringer Ingelheim's Yamagata site is gradually switching to a more sustainable energy supply.
Performance Indicators

Performance Indicators

Performance indicators concerning Environment Health and Safety (EHS) are summarized here.
Światowy Dzień Chorób Rzadkich 2021

Światowy Dzień Chorób Rzadkich 2021

Rzadkie, ale nie zapomniane: dlaczego wsparcie medyczne dla około 30 milionów osób w UE cierpiących na choroby rzadkie1 jest nie do przecenienia